Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL©) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change
This study extends the evidence for the longitudinal validity of the HidroQoL© up to 72 weeks and proposed MWPC thresholds for different time intervals (4 and 12 weeks) after baseline, aiding interpretability. Results concur with findings from previous validation studies.
Authors
- Christoph Abels (ORCID: https://orcid.org/0000-0002-7778-7740)
- Paul Kamudoni (ORCID: https://orcid.org/0000-0002-4669-0647)
- Clarissa Masur (ORCID: https://orcid.org/0000-0001-7361-727X)
- Sam Salek (ORCID: https://orcid.org/0000-0002-4612-5699)
- Theresa Donhauser (ORCID: https://orcid.org/0000-0002-0640-1169)
- Christian Apfelbacher (ORCID: https://orcid.org/0000-0003-3805-8219)
- Michaela Gabes (ORCID: https://orcid.org/0000-0003-1672-7549)
Institutions
- University of Hertfordshire (GB)
- Deutsche Bundespost (DE)
- Technische Universität Darmstadt (DE)
- Dr. August Wolff (Germany) (DE)
- Institute of Economic Development (GB)
- Institute of Development Studies (GB)
- Institute of Development Studies (IN)
- University of Regensburg (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1093/bjd/ljae415
- Citations
- 2
- Primary Topic
- Sympathectomy and Hyperhidrosis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.65